Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 12, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions
Multiple Sclerosis
Interventions
DRUG

Dalfampridine 10 MG [Ampyra]

Dalfampridine (10 mg) every 12 hours for 6 weeks.

BEHAVIORAL

Physical therapy

Physical therapy (motor relearning for mobility and balance) one-on-one twice per week for 6 weeks.

OTHER

Dalfampridine plus physical therapy

Dalfampridine (10 mg) every 12 hours for 6 weeks while simultaneously receiving physical therapy (motor relearning for mobility and balance) one-on-one twice per week.

Trial Locations (1)

02129

RECRUITING

MGH Institute of Health Professions, Boston

All Listed Sponsors
lead

MGH Institute of Health Professions

OTHER